With volatile market conditions and recent FDA shakeups, biotech companies are increasingly focused on bolstering cash runways and accelerating R&D efforts. But fierce competition for financing has some biotechs turning to...more
Companies are transforming legacy systems, implementing automation and artificial intelligence tools, embedding digital capabilities into their products, shifting to cloud solutions and leveraging technology to better connect...more
Keeping Intellectual Property (IP) recordal projects under control can sometimes be a daunting task. With the exception of certain transactions, such as stock purchase agreements, recently acquired intellectual property...more